基本資料
種類: ETF
費用比率%: 0.75
資產淨值: 27.96
成立日期: 31/10/2014
 
分析
市值分佈:
37.00%
大市值
37.55%
中市值
25.34%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:58) 總持有投資項目: 34  
0%
 
100%
     10大 (59.13%)
代號 名稱 佔比% 持有日期
CRSPCRISPR Therapeutics AG9.3626/02/2026
TEMTempus AI Inc.8.5326/02/2026
TWSTTwist Bioscience Corp8.5226/02/2026
PSNLPersonalis5.6726/02/2026
BEAMBeam Therapeutics5.4526/02/2026
TXG10x Genomics5.2926/02/2026
GHGuardant Health4.3226/02/2026
NTRANatera4.1026/02/2026
ILMNIllumina3.9726/02/2026
RXRXRecursion Pharmaceuticals3.9226/02/2026
CDNACareDx3.3226/02/2026
NTLAIntellia Therapeutics3.3126/02/2026
VCYTVeracyte3.2126/02/2026
ADPTAdaptive Biotechnologies Corp2.8526/02/2026
ABSIAbsci Corp2.7026/02/2026
IONSIonis Pharmaceuticals2.6726/02/2026
NRIXNurix Therapeutics2.0626/02/2026
SDGRSchrodinger2.0526/02/2026
CMPSCOMPASS Pathways Plc1.7826/02/2026
ARCTArcturus Therapeutics Holdings1.7826/02/2026
 1    2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.